Treatment of acute hereditary angioedema attacks with subcutaneous injections of bradikinin II receptor antagonist and kalikrein inhibitor, with excellent clinical outcomes, preventing the evolving acute angioedema and reducing therefore its potential fatal complications are now available. New promissing oral and sublingual immunotherapy are being investigated in the area of food allergy. New immunomodulatory treatments with monoclonal antibodies are being proposed for a better control of allergic asthma and rhinitis and also of atopic dermatitis.

Copyright © 2010 Clínica Geller. Todos os direitos reservados.